GENEXINE, INC. AND TASGEN BIO-TECH (TIANJIN) CO., LTD. INTELLECTUAL PROPERTY ASSIGNMENT AND LICENSE AGREEMENT DATED October 16th, 2015Intellectual Property Assignment and License Agreement • October 4th, 2019 • I-Mab • Pharmaceutical preparations
Contract Number: Product Development Agreement of TG103 Project Between I-Mab Biopharma (Shanghai) Co., Ltd. and CSPC Baike (Shangdong) Biopharmaceutical Co., Ltd. December 10th, 2018Product Development Agreement • October 4th, 2019 • I-Mab • Pharmaceutical preparations
This Intellectual Property Licensing and Product Development Agreement (“this Agreement”) is signed by and between the following parties on December 10th, 2018:
SUPPLEMENTAL AGREEMENT TO CD38 PRODUCT COLLABORATION AGREEMENTCd38 Product Collaboration Agreement • October 4th, 2019 • I-Mab • Pharmaceutical preparations
